Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRB | P24530 | 1/20 | 0.36 |
| ▸ | EDNRA | P25101 | 1/20 | 0.36 |
| ▸ | OPRL1 | P41146 | 7/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluacrypyrim SCHEMBL83958 | 0.87 | HIF1A (0.37) | EDNRBEDNRAOPRL1CYP1A2HIF1A | |
| Fluacrypyrim SCHEMBL29413955 | 0.87 | HIF1A (0.37) | EDNRBEDNRAOPRL1CYP1A2HIF1A | |
| Fluacrypyrim SCHEMBL682688 | 0.87 | HIF1A (0.37) | EDNRBEDNRAOPRL1CYP1A2HIF1A | |
| Fluacrypyrim SCHEMBL5997532 | 0.87 | HIF1A (0.37) | EDNRBEDNRAOPRL1CYP1A2HIF1A | |
| SCHEMBL10020202 | 0.82 | OPRL1 (0.38) | OPRL1HIF1A | |
| SCHEMBL8723182 | 0.80 | HIF1A (0.44) | OPRL1HIF1A | |
| SCHEMBL8723178 | 0.80 | HIF1A (0.44) | OPRL1HIF1A | |
| SCHEMBL12671601 | 0.79 | GABRA5 (0.39) | KMT2AMEN1HIF1A | |
| SCHEMBL9256030 | 0.79 | GABRA5 (0.39) | KMT2AMEN1HIF1A | |
| SCHEMBL3110515 | 0.79 | PTGS1 (0.36) | EDNRBEDNRAOPRL1CYP1A2HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160044921-A1 | SYNERGISTIC ACTIVE INGREDIENT COMBINATIONS | BAYER CROPSCIENCE AG (DE) | 2016-02-18 | — | — | US | disclosed |
| US-20140287915-A1 | SYNERGISTIC ACTIVE INGREDIENT COMBINATIONS | BAYER CROPSCIENCE AG (DE) | 2014-09-25 | — | — | US | disclosed |
| US-20110275583-A1 | Synergistic active compound combinations | BAYER CROPSCIENCE AG (DE) | 2011-11-10 | — | — | US | disclosed |
| US-20110124588-A1 | SYNERGISTIC ACTIVE INGREDIENT COMBINATIONS | BAYER CROPSCIENCE AG (DE) | 2011-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160044921-A1 | SYNERGISTIC ACTIVE INGREDIENT COMBINATIONS | ACHE, ACAT2, ACAT1 | EDNRB 4705/4885EDNRA 4742/4885OPRL1 3701/4885 |
| US-20110124588-A1 | SYNERGISTIC ACTIVE INGREDIENT COMBINATIONS | ACHE, ACAT2, ACAT1 | EDNRB 4705/4885EDNRA 4742/4885OPRL1 3701/4885 |
| US-20140287915-A1 | SYNERGISTIC ACTIVE INGREDIENT COMBINATIONS | ACHE, ACAT2, ACAT1 | EDNRB 4705/4885EDNRA 4742/4885OPRL1 3701/4885 |
| US-20110275583-A1 | Synergistic active compound combinations | ACHE, ACAT2, ACAT1 | EDNRB 4373/4885EDNRA 4490/4885OPRL1 3260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.